Fielmann Group AG (FIED.XC)
- Previous Close
57.10 - Open
55.70 - Bid 40.45 x --
- Ask --
- Day's Range
57.10 - 57.10 - 52 Week Range
39.92 - 57.10 - Volume
276 - Avg. Volume
24 - Market Cap (intraday)
4.796B - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
29.43 - EPS (TTM)
1.94 - Earnings Date Aug 28, 2025
- Forward Dividend & Yield 1.15 (2.01%)
- Ex-Dividend Date Jul 11, 2025
- 1y Target Est
--
Fielmann Group AG engages in vision care and audiology in Germany, Switzerland, Austria, and internationally. The company manufactures and sells visual aids mainly glasses, frames, lenses, sunglasses, contact lenses, accessories, hearing aids systems and its accessories, as well as personal protective equipment. It offers its products under the fielmann, Optika Clarus, Optica & Audiologia Universitaria, Medical optica audicion, and SVS VISION brand names. The company sells its products through digital sales, retail stores, as well as Befitting, an optical e-commerce platform. The company was formerly known as Fielmann Aktiengesellschaft and changed its name to Fielmann Group AG in July 2023. Fielmann Group AG was founded in 1972 and is headquartered in Hamburg, Germany. The company is a subsidiary of Korva SE.
www.fielmann-group.com20,221
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: FIED.XC
View MorePerformance Overview: FIED.XC
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FIED.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FIED.XC
View MoreValuation Measures
Market Cap
4.70B
Enterprise Value
5.48B
Trailing P/E
29.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.05
Price/Book (mrq)
5.33
Enterprise Value/Revenue
2.35
Enterprise Value/EBITDA
13.71
Financial Highlights
Profitability and Income Statement
Profit Margin
6.98%
Return on Assets (ttm)
--
Return on Equity (ttm)
18.64%
Revenue (ttm)
2.33B
Net Income Avi to Common (ttm)
162.62M
Diluted EPS (ttm)
1.94
Balance Sheet and Cash Flow
Total Cash (mrq)
101.68M
Total Debt/Equity (mrq)
95.70%
Levered Free Cash Flow (ttm)
--